Cited by 555Iron Metabolism and DisordersFerroptosis and cancer prognosisNeurological diseases and metabolism

The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin

Open access
Silvestri, Laura, Pagani, Alessia, Nai, Antonella, De Domenico, Ivana, Kaplan, Jerry, Camaschella, Clara·2008·Cell Metabolism

Abstract

The liver peptide hepcidin regulates body iron, is upregulated in iron overload and inflammation, and is downregulated in iron deficiency/hypoxia. The transmembrane serine protease matriptase-2 (TMPRSS6) inhibits the hepcidin response and its mutational inactivation causes iron-deficient anemia in mice and humans. Here we confirm the inhibitory effect of matriptase-2 on hepcidin promoter; we show that matriptase-2 lacking the serine protease domain, identified in the anemic Mask mouse (matriptase-2(MASK)), is fully inactive and that mutant R774C found in patients with genetic iron deficiency has decreased inhibitory activity. Matriptase-2 cleaves hemojuvelin (HJV), a regulator of hepcidin, on plasma membrane; matriptase-2(MASK) shows no cleavage activity and the human mutant only partial cleavage capacity. Matriptase-2 interacts with HJV through the ectodomain since the interaction is conserved in matriptase-2(MASK). The expression of matriptase-2 mutants in zebrafish results in anemia, confirming the matriptase-2 role in iron metabolism and its interaction with HJV.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2008.09.012

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most powerful inhibitor is the liver transmembrane serine protease matriptase 2, encoded by TMPRSS6, which cleaves the BMP co-receptor hemojuvelin, thereby attenuating BMP-SMAD signaling and hepcidin transcription.

    “The most powerful inhibitor is the liver transmembrane serine protease matriptase 2, encoded by TMPRSS6,48 which cleaves the BMP co-receptor hemojuvelin,49 thereby attenuating BMP-SMAD signaling and hepcidin transcription.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • University of Utah (US)
Corresponding author
Camaschella, Clara
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2008-12
Volume
8
Issue
6
Pages
502-511
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2012956876
Cited by
555
References
9
Citations by year
2026: 10 · 2025: 18 · 2024: 12 · 2023: 23 · 2022: 26 · 2021: 27 · 2020: 19 · 2019: 32 · 2018: 27 · 2017: 36 · 2016: 32 · 2015: 29 · 2014: 35 · 2013: 41 · 2012: 47
FWCI
30.47
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Fondazione Telethon
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK070947, R01DK070947)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
matriptase-2, TMPRSS6, hepcidin, hemojuvelin, serine protease, iron metabolism, iron deficiency anemia, zebrafish, proteolytic cleavage
MeSH terms
Hemochromatosis Protein, Animals, Cell Membrane, Cells, Cultured, Endoplasmic Reticulum, HeLa Cells, Humans, Membrane Proteins, Promoter Regions, Genetic, Protein Processing, Post-Translational, Serine Endopeptidases, Zebrafish, Signal Transduction, Amino Acid Substitution, Antimicrobial Cationic Peptides, GPI-Linked Proteins, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review